Oral Anticoagulant Therapy: Quality-of-Life Issues

ABSTRACT

Developments in the management and appropriate use of oral anticoagulant therapy have resulted in improved clinical outcomes for patients. Additionally, the results of randomized clinical trials have defined the appropriate indications for oral anticoagulant therapy. These advancements have provided both clinicians and patients with the evidence needed to make informed decisions about the use of anticoagulant therapy. The changes in behavior and lifestyle modifications imposed by oral anticoagulant therapy may affect the quality-of-life of patients. Recent studies have begun to examine issues surrounding oral anticoagulant therapy. As clinicians and patients weigh the evidence of the risks and benefits of oral anticoagulant therapy, they need to implicitly consider quality-of-life issues that may influence their decision-making.

KEYWORDS

Oral anticoagulant therapy - quality-of-life issues - thromboembolism treatment

REFERENCES

• 1 Guyatt G H. Health status, quality of life, and the individual.  JAMA . 1994;  272 630-631
• 2 Anderson R J, Reed W G. Current concepts in treatment of hypertensive urgencies.  Am Heart J . 1986;  111 211-219
• 3 Pearlman R A, Jonsen A. The use of quality of life consideration in medical decision-making.  J Am Geriatr Soc . 1985;  33 344-352
• 4 Gelber R D, Lenderking W R, Cotton D J. et al . Quality of life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection.  Ann Intern Med . 1992;  116 961-966
• 5 Pearlman R A, Uhlmann R F. Quality of life in elderly, chronically ill outpatients.  J Gerontol . 1991;  46 M31-M38
• 6 Katz S. The science of quality of life.  J Chron Dis . 1987;  40 459-463
• 7 Gill T M, Feinstein A R. A critical appraisal of the quality of life measurements.  JAMA . 1994;  272 619-626
• 8 Tsevat J, Eckman M H, McNutt R A, Pauker S G. Warfarin for dilated cardiomyopathy: a bloody tough pill to swallow.  Med Decis Making . 1989;  9 162-169
• 9 Torrance G W. Utility approach to measuring health-related quality of life.  J Chron Dis . 1987;  40 593-600
• 10 O'Connor G T, Nease R F. The descriptive epidemiology of the health-state values and utilities.  Med Decis Making . 1993;  13 87-88
• 11 Gage B F, Cardinalli A B, Owens D K. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life.  Arch Intern Med . 1996;  156 1829-1836
• 12 Nease R F, Owens D K. A method for estimating the cost-effectiveness of incorporating patient preferences into practice guidelines.  Med Decis Making . 1994;  14 382-392
• 13 Nease R F, Kneeland T, O'Connor G T, for the Ischemic Heart Disease Patient Outcomes Research Team. et al . Variation in patient utilities for outcomes of the management of chronic stable angina for clinical practice guidelines.  JAMA . 1995;  273 1185-1190
• 14 Solomon N A, Glick H A, Russo C J, Lee J, Schulman K A. Patient preferences for stroke outcomes.  Stroke . 1994;  25 320-327
• 15 Lancaster T R, Singer D E, Sheehan M A. et al . The impact of long-term warfarin therapy on quality of life: evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.  Arch Intern Med . 1991;  151 1944-1949
• 16 Hirsh J. Influence of low-intensity warfarin treatment on patients' perceptions of quality of life.  Arch Intern Med . 1991;  151 1921-1922
• 17 McCrory D C, Matchar D B, Samsa G, Sanders L L, Pritchett E LC. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation.  Arch Intern Med . 1995;  155 277-281
• 18 Barcellona D, Contu P, Sorano G G, Pengo V, Marongiu F. The management of oral anticoagulant therapy: the patient's point of view.  Thromb Haemostasis . 2000;  83 49-53
• 19 Kulinna W, Ney D, Wenzel T, Heene D L, Harenberg J. The effect of self-monitoring the INR on quality of anticoagulation and quality of life.  Semin Thrombosis Hemost . 1999;  25 123-126